Description

Molecular representation of GPR18 receptor interactions with phytocannabinoid compounds. GPR18 is expressed in brain tissue and may contribute to the complex pharmacology of cannabis-derived antiepileptic effects.

Figure 73

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 73: Molecular representation of GPR18 receptor interactions with phytocannabinoid compounds. GPR18 is expressed in brain tissue and may contribute to the complex pharmacology of cannabis-derived antiepileptic effects.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Molecular representation of GPR18 receptor interactions with phytocannabinoid compounds. GPR18 is expressed in brain tissue and may contribute to the complex pharmacology of cannabis-derived antiepileptic effects." />
  <figcaption>Figure 73. Molecular representation of GPR18 receptor interactions with phytocannabinoid compounds. GPR18 is expressed in brain tissue and may contribute to the complex pharmacology of cannabis-derived antiepileptic effects.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Preuves associées

CBD pour Insomnie

Note A · 103 études